Yamazaki R, Tsuchida K, Aihara H
Research Center, Taisho Pharmaceutical Co., Ltd., Saitama, Japan.
Arch Int Pharmacodyn Ther. 1988 Sep-Oct;295:80-93.
The alpha-adrenoceptor agonist ST-1059 (2-amino-1-(2,5-dimethoxyphenyl) ethanol), the alpha 1-adrenoceptor agonist methoxamine, the alpha 2-adrenoceptor agonist clonidine and a nonselective alpha-adrenoceptor agonist norepinephrine, all increase cardiac output and dose-dependently increase arterial blood pressure in spinally anesthetized ganglion-blocked dogs. The increase in cardiac output may be the result of an increased venous return via the contraction of capacitance vessels, and the vasopressor responses are attributed to an increase in total peripheral resistance. The increases in cardiac output and pressor responses induced by ST-1059 and methoxamine were antagonized by the alpha 1-adrenoceptor antagonist prazosin (0.3 mg/kg i.v.), but those induced by clonidine were not inhibited. In contrast, the alpha 2-adrenoceptor antagonist yohimbine (0.3 mg/kg i.v.) had little or no effects on the increase in cardiac output or the pressor responses induced by ST-1059 and methoxamine, but strongly attenuated those of clonidine. Prazosin and yohimbine inhibited the norepinephrine-induced increase in cardiac output and pressor responses. These results suggest that the increases in cardiac output and blood pressure induced by ST-1059 were mediated by postjunctional alpha 1-adrenoceptor stimulation, such as by methoxamine, but that those induced by clonidine were mediated by postjunctional alpha 2-adrenoceptor stimulation in dogs. Not only the postjunctional alpha 1-adrenoceptors but also the postjunctional alpha 2-adrenoceptors may play an important role in the constriction of venous beds, as well as of the arterioles in spinally anesthetized ganglion-blocked dogs.
α-肾上腺素能受体激动剂ST-1059(2-氨基-1-(2,5-二甲氧基苯基)乙醇)、α1-肾上腺素能受体激动剂甲氧明、α2-肾上腺素能受体激动剂可乐定以及非选择性α-肾上腺素能受体激动剂去甲肾上腺素,均可增加脊髓麻醉且神经节阻断犬的心输出量,并呈剂量依赖性地升高动脉血压。心输出量的增加可能是由于容量血管收缩导致静脉回心血量增加所致,而升压反应则归因于总外周阻力的增加。ST-1059和甲氧明诱导的心输出量增加和升压反应被α1-肾上腺素能受体拮抗剂哌唑嗪(静脉注射0.3mg/kg)拮抗,但可乐定诱导的反应未被抑制。相反,α2-肾上腺素能受体拮抗剂育亨宾(静脉注射0.3mg/kg)对ST-1059和甲氧明诱导的心输出量增加或升压反应几乎没有影响,但能强烈减弱可乐定诱导的反应。哌唑嗪和育亨宾抑制去甲肾上腺素诱导的心输出量增加和升压反应。这些结果表明,ST-1059诱导的心输出量和血压升高是由节后α1-肾上腺素能受体刺激介导的,如甲氧明,但可乐定诱导的反应是由犬的节后α2-肾上腺素能受体刺激介导的。不仅节后α1-肾上腺素能受体,节后α2-肾上腺素能受体在脊髓麻醉且神经节阻断犬的静脉床以及小动脉收缩中可能也起着重要作用。